2001 THE REGISTRY OF THE INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION: EIGHTEENTH ANNUAL REPORT.

Slides:



Advertisements
Similar presentations
HEART TRANSPLANTATION
Advertisements

Donors Per Million Population
Progress Against Leukemia. 1970–1979 Progress Against Leukemia 1970– : FDA approves doxorubicin.
OPTN Modifications to Heart Allocation Policy Implemented July 12, 2006 Changed the allocation order for medically urgent (Status 1A and 1B) patients Policy.
OPTN HEART ALLOCATION SYSTEM DATA UPDATE Based on OPTN data as of July 16, 2010 Fall 2010 Regional Meetings.
ISHLT/MCSD Analysis: Jan 2002 – Dec 2004, n= Deaths * censored at transplant Percent Survival Months after Device Implant Deaths / Month Event:
ISHLT/MCSD Analysis: Jan 2002 – Dec 2004, n= Deaths * censored at transplant Percent Survival Months after Device Implant Deaths / Month Event:
2002 ISHLT HEART TRANSPLANTATION Pediatric Recipients.
HEART-LUNG TRANSPLANTATION Overall ISHLT 2006 J Heart Lung Transplant 2006;25:
2002 ISHLT HEART TRANSPLANTATION Overall ISHLT NUMBER OF HEART TRANSPLANTS REPORTED BY YEAR * Numbers may be low due to delayed reporting. Number.
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2006 J Heart Lung Transplant 2006;25:
HEART-LUNG TRANSPLANTATION Overall ISHLT 2005 J Heart Lung Transplant 2005;24:
THE REGISTRY OF THE INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION: TWENTY-THIRD ANNUAL REPORT ISHLT 2006 J Heart Lung Transplant 2006;25:
HEART TRANSPLANTATION Overall ISHLT 2006 J Heart Lung Transplant 2006;25:
HEART TRANSPLANTATION Overall ISHLT 2008 J Heart Lung Transplant 2008;27:
HEART TRANSPLANTATION Pediatric Recipients ISHLT 2006 J Heart Lung Transplant 2006;25:
2004 ISHLT J Heart Lung Transplant 2004; 23: HEART TRANSPLANTATION Pediatric Recipients.
2002 ISHLT J Heart Lung Transplant 2002; 21: HEART TRANSPLANTATION Overall.
J Heart Lung Transplant 2009;28: LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2009.
2002 ISHLT J Heart Lung Transplant 2002; 21: HEART-LUNG TRANSPLANTATION Overall.
2002 ISHLT J Heart Lung Transplant 2002; 21: THE REGISTRY OF THE INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION: NINETEENTH ANNUAL REPORT.
2004 ISHLT J Heart Lung Transplant 2004; 23: HEART-LUNG TRANSPLANTATION Overall.
J Heart Lung Transplant 2009;28: HEART TRANSPLANTATION Overall ISHLT 2009.
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2008 J Heart Lung Transplant 2008;27:
2004 ISHLT J Heart Lung Transplant 2004; 23: LUNG TRANSPLANTATION Pediatric Recipients.
J Heart Lung Transplant 2009;28: HEART TRANSPLANTATION Pediatric Recipients ISHLT 2009.
2003 ISHLT J Heart Lung Transplant 2003; 22: HEART TRANSPLANTATION Overall.
HEART-LUNG TRANSPLANTATION
2003 ISHLT J Heart Lung Transplant 2003; 22: LUNG TRANSPLANTATION Pediatric Recipients.
2003 ISHLT J Heart Lung Transplant 2003; 22: HEART TRANSPLANTATION Pediatric Recipients.
2003 ISHLT J Heart Lung Transplant 2003; 22: HEART-LUNG TRANSPLANTATION Overall.
LUNG TRANSPLANTATION Pediatric Recipients 2011 ISHLT J Heart Lung Transplant Oct; 30 (10):
2001 J Heart Lung Transplant 2001; 20: ; 2002: 21: THE REGISTRY OF THE INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION: EIGHTEENTH.
HEART-LUNG TRANSPLANTATION Overall ISHLT 2008 J Heart Lung Transplant 2008;27:
THE REGISTRY OF THE INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION: TWENTY-FOURTH ANNUAL REPORT ISHLT 2007 J Heart Lung Transplant 2007;26:
2002 ISHLT J Heart Lung Transplant 2002; 21: HEART TRANSPLANTATION Pediatric Recipients.
HEART TRANSPLANTATION Pediatric Recipients 2010 ISHLT J Heart Lung Transplant Oct; 29 (10):
HEART TRANSPLANTATION
HEART-LUNG TRANSPLANTATION Overall 2010 ISHLT J Heart Lung Transplant Oct; 29 (10):
HEART TRANSPLANTATION Pediatric Recipients ISHLT 2007 J Heart Lung Transplant 2007;26:
HEART-LUNG TRANSPLANTATION
2002 ISHLT J Heart Lung Transplant 2002; 21: LUNG TRANSPLANTATION Pediatric Recipients.
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2005 J Heart Lung Transplant 2005;24:
2004 ISHLT J Heart Lung Transplant 2004; 23: HEART TRANSPLANTATION Overall.
HEART TRANSPLANTATION Pediatric Recipients ISHLT 2008 J Heart Lung Transplant 2008;27:
HEART TRANSPLANTATION Overall ISHLT 2005 J Heart Lung Transplant 2005;24:
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2007 J Heart Lung Transplant 2007;26.
HEART-LUNG TRANSPLANTATION
Surgery volume and operative mortality: A re-examination using fixed-effects regression Amresh Hanchate, PhD Section of General Internal Medicine Boston.
Chapter 5: Workforce. Chartbook 2003 Physician Workforce After dropping slightly in 1999, the number of active physicians per thousand population rose.
School Shop. Welcome to my shop. You have 10p How much change will you get? 7p 3p change.
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2012 Summary Slides SUM12_1.ppt.
CURRENT STATE OF LIVER ALLOCATION AND DISTRIBUTION John R. Lake, MD University of Minnesota Medical School.
Scottish Intensive Care Society Audit Group, Annual Report Note from Scottish Intensive Care Society Audit Group.
Adding Up In Chunks.
UK Renal Registry 17th Annual Report Figure 5.1. Trend in one year after 90 day incident patient survival by first modality, 2003–2012 cohorts (adjusted.
THE AUSTRALIA AND NEW ZEALAND CARDIOTHORACIC ORGAN TRANSPLANT REGISTRY EIGHTEENTH ANNUAL REPORT 1984 – 2013 ANZCOTR 2013.
HEART TRANSPLANTATION Adult Recipients JHLT Oct; 32(10):
HEART-LUNG TRANSPLANTATION Overall 2014 JHLT Oct; 33(10):
Optimizing lung transplant outcomes in the adult and pediatric patient. Cynthia S. Herrington, MD Associate Professor of Surgery Keck School of Medicine.
Table 1 Cause of death for arrested organ donors
EUROPEAN LIVER TRANSPLANT REGISTRY
Risk factors in deceased-donor transplants Risk factor 1988
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2010
HEART-LUNG TRANSPLANTATION
Pretransplant Panel Reactive Antibodies in Human Lung Transplantation: An Analysis of Over 10,000 Patients  Ashish S. Shah, MD, Lois Nwakanma, MD, Christopher.
Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure  Erin M. Schumer,
Heart Transplant Program Volume Is Not a Measure of Quality
A: Comparison of pediatric lung transplant survival between different age groups. A: Comparison of pediatric lung transplant survival between different.
HEART-LUNG TRANSPLANTATION
Presentation transcript:

2001 THE REGISTRY OF THE INTERNATIONAL SOCIETY FOR HEART AND LUNG TRANSPLANTATION: EIGHTEENTH ANNUAL REPORT

2001 ACKNOWLEDGMENTS: We wish to extend our sincere thanks to the many thoracic transplant surgeons, physicians and data coordinators in transplant programs throughout the world whose timely and accurate submission of data has made these analyses possible.

2001 REGISTRY DATABASE

2001 REGISTRY DATABASE

2001 HEART TRANSPLANTATION * Numbers may be low due to incomplete reporting. Number of Transplants * * 12% 9% 6% 3% % donors % donors 50+ Percent of Donors by Age

2001 AGE DISTRIBUTION OF HEART RECIPIENTS ( ) % of Trnsplants % of Transplants

2001 ADULT HEART TRANSPLANTATION INDICATIONS

2001 AGE DISTRIBUTION OF PEDIATRIC HEART RECIPIENTS Number of Transplants

2001 PEDIATRIC HEART TRANSPLANTATION INDICATIONS BY AGE ( ) < 1 Year1-10 Years11-17 Years

2001 HEART TRANSPLANTATION ACTUARIAL SURVIVAL ( ) N=52,195 Half-life =9.1 years Conditional Half-life = 11.6 years

2001 ADULT HEART TRANSPLANTATION ACTUARIAL SURVIVAL All comparisons with are significant at p < Survival (%)

2001 ADULT HEART RE-TRANSPLANTATION ( ) 1 Year Patient Survival (%)

2001 ADULT HEART TRANSPLANTATION RISK FACTORS FOR 1 YEAR MORTALITY N=38,943

2001 ADULT HEART TRANSPLANTATION RISK FACTORS FOR 1 YEAR MORTALITY N=38,943 * * Latest period in cohort

2001 ADULT HEART TRANSPLANTATION RISK FACTORS FOR 1 YEAR MORTALITY N=38,943

2001 ADULT HEART TRANSPLANTATION RISK FACTORS FOR 1 YEAR MORTALITY N=38,943

2001 ADULT HEART TRANSPLANTATION RISK FACTORS FOR 1 YEAR MORTALITY N=38,943

2001 ADULT HEART TRANSPLANTATION RISK FACTORS FOR 5 YEAR MORTALITY N=26,250

2001 ADULT HEART TRANSPLANTATION RISK FACTORS FOR 5 YEAR MORTALITY N=26,250

2001 ADULT HEART TRANSPLANTATION RISK FACTORS FOR 5 YEAR MORTALITY N=26,250

2001 ADULT HEART TRANSPLANTATION RISK FACTORS FOR 5 YEAR MORTALITY N=26,250

2001 PEDIATRIC HEART TRANSPLANTATION ACTUARIAL SURVIVAL ( ) All comparisons with <1 year significant at p <

2001 PEDIATRIC HEART TRANSPLANTATION RISK FACTORS FOR 1 YEAR MORTALITY N=3,760 * Earliest period in cohort *

2001 PEDIATRIC HEART TRANSPLANTATION RISK FACTORS FOR 1 YEAR MORTALITY N=3,760

2001 PEDIATRIC HEART TRANSPLANTATION RISK FACTORS FOR 5 YEAR MORTALITY N=2,465 * Latest year in cohort *

2001 PEDIATRIC HEART TRANSPLANTATION RISK FACTORS FOR 5 YEAR MORTALITY N=2,465

2001 PEDIATRIC HEART TRANSPLANTATION RISK FACTORS FOR 5 YEAR MORTALITY N=2,465

2001 FUNCTIONAL STATUS Heart (April 1994-Dec. 2000)

2001 EMPLOYMENT STATUS Heart (US Data: April 1994-Dec. 2000)

2001 REHOSPITALIZATION POST HEART TRANSPLANTATION (April Dec. 2000)

2001 HEART TRANSPLANT MAINTENANCE IMMUNOSUPPRESSION % of Patients

2001 HEART TRANSPLANTATION Donor age versus Ejection Fraction yr 1 to yr 2

2001 POST-HEART TRANSPLANT MORBIDITY (April 1994-December 2000)

2001 ADULT HEART TRANSPLANTATION RISK FACTORS FOR CAV WITHIN 3 YEARS N=7,691

2001 ADULT HEART TRANSPLANTATION RISK FACTORS FOR CAV WITHIN 3 YEARS N=7,691

2001 MALIGNANCY POST-HEART TRANSPLANTATION (April 1994-December 2000) 1-Year Followup 5-Year Followup

2001 HEART TRANSPLANTS: CAUSE OF DEATH ( ) Timing of Death Cause of Death (%)

2001 HEART-LUNG TRANSPLANTATION

2001 ADULT HEART-LUNG TRANSPLANTATION INDICATIONS ( )

2001 HEART-LUNG TRANSPLANTATION ACTUARIAL SURVIVAL ( ) N=2,550 Half-life = 2.8 years Conditional Half-life = 8.2 years Survival (%)

2001 LUNG TRANSPLANTATION Mean Donor Age

2001 AGE DISTRIBUTION OF LUNG TRANSPLANTATION

2001 ADULT LUNG TRANSPLANTATION INDICATIONS ( ) Single Lung Bilateral/Double Lung

2001 PEDIATRIC LUNG TRANSPLANTATION AGE DISTRIBUTION ( ) Number of Transplants

2001 PEDIATRIC LUNG TRANSPLANTATION INDICATIONS ( )

2001 LUNG TRANSPLANTATION ACTUARIAL SURVIVAL ( ) Double lung: 1/2-life = 4.5 Years; Conditional 1/2-life = 7.9 Years Single lung: 1/2-life = 3.6 Years; Conditional 1/2-life = 5.7 Years All lungs: 1/2-life = 3.8 Years; Conditional 1/2-life = 6.3 Years

2001 ADULT LUNG TRANSPLANTATION ACTUARIAL SURVIVAL ( ) Comparison of vs was significant at p = 0.002

2001 PEDIATRIC LUNG/HRT-LUNG TRANSPLANTATION ACTUARIAL SURVIVAL ( )

2001 ADULT LUNG TRANSPLANTATION RISK FACTORS FOR 1 YEAR MORTALITY N=9,653 * Earliest period in cohort *

2001 ADULT LUNG TRANSPLANTATION RISK FACTORS FOR 1 YEAR MORTALITY N=9,653

2001 ADULT LUNG TRANSPLANTATION RISK FACTORS FOR 1 YEAR MORTALITY N=9,653

2001 ADULT LUNG TRANSPLANTATION RISK FACTORS FOR 1 YEAR MORTALITY N=9,653

2001 ADULT LUNG TRANSPLANTATION RISK FACTORS FOR 1 YEAR MORTALITY N=9,653

2001 ADULT LUNG TRANSPLANTATION RISK FACTORS FOR 5 YEAR MORTALITY N=5,050 * Earliest period in cohort *

2001 ADULT LUNG TRANSPLANTATION RISK FACTORS FOR 5 YEAR MORTALITY N=5,050

2001 ADULT LUNG TRANSPLANTATION RISK FACTORS FOR 5 YEAR MORTALITY N=5,050

2001 ADULT LUNG TRANSPLANTATION RISK FACTORS FOR 5 YEAR MORTALITY N=5,050

2001 FUNCTIONAL STATUS Lung (April 1994-December 2000)

2001 EMPLOYMENT STATUS Lung (US: April 1994-December 2000)

2001 REHOSPITALIZATION POST LUNG TRANSPLANTATION (April December 2000)

2001 POST-LUNG TRANSPLANT MORBIDITY (April 1994-December 2000)

2001 ADULT LUNG TRANSPLANTATION RISK FACTORS FOR BRONCHIOLITIS WITHIN 3 YEARS N=2,756 ** Latest year in cohort * Earliest year in cohort * **

2001 ADULT LUNG TRANSPLANTATION RISK FACTORS FOR BRONCHIOLITIS WITHIN 3 YEARS N=2,756

2001 ADULT LUNG TRANSPLANTATION RISK FACTORS FOR BRONCHIOLITIS WITHIN 3 YEARS N=2,756

2001 MALIGNANCY POST-LUNG TRANSPLANTATION (April 1994-December 2000) 1-Year Followup 5-Year Followup

2001 LUNG TRANSPLANTS: CAUSE OF DEATH ( ) Timing of Death Cause of Death (%)